SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 222 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $209 | -16.7% | 7,570 | 0.0% | 0.02% | -20.0% |
| Q2 2023 | $251 | -8.4% | 7,570 | 0.0% | 0.02% | -9.1% |
| Q1 2023 | $274 | +1.5% | 7,570 | 0.0% | 0.02% | -4.3% |
| Q4 2022 | $270 | -99.9% | 7,570 | 0.0% | 0.02% | -4.2% |
| Q3 2022 | $256,000 | -5.9% | 7,570 | -10.2% | 0.02% | +14.3% |
| Q1 2022 | $272,000 | -15.0% | 8,430 | -18.8% | 0.02% | -19.2% |
| Q2 2021 | $320,000 | +17.6% | 10,380 | 0.0% | 0.03% | +4.0% |
| Q1 2021 | $272,000 | +4.2% | 10,380 | 0.0% | 0.02% | 0.0% |
| Q4 2020 | $261,000 | +20.8% | 10,380 | 0.0% | 0.02% | +4.2% |
| Q3 2020 | $216,000 | -13.6% | 10,380 | 0.0% | 0.02% | -17.2% |
| Q2 2020 | $250,000 | +33.7% | 10,380 | 0.0% | 0.03% | +11.5% |
| Q1 2020 | $187,000 | -19.4% | 10,380 | +47.9% | 0.03% | -31.6% |
| Q2 2019 | $232,000 | -5.7% | 7,020 | 0.0% | 0.04% | -11.6% |
| Q1 2019 | $246,000 | +20.0% | 7,020 | +105.3% | 0.04% | 0.0% |
| Q2 2018 | $205,000 | – | 3,420 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 699,432 | $35,216,000 | 4.25% |
| Provident Investment Management, Inc. | 590,269 | $29,720,000 | 4.23% |
| CAPITAL MANAGEMENT CORP /VA | 225,232 | $11,340,000 | 2.90% |
| FALCON POINT CAPITAL, LLC | 188,341 | $9,483,000 | 2.04% |
| Ranger Investment Management | 600,464 | $30,233,000 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 471,260 | $23,728,000 | 1.96% |
| KOPP INVESTMENT ADVISORS LLC | 41,700 | $2,100,000 | 1.77% |
| SHAKER INVESTMENTS LLC/OH | 49,617 | $2,498,000 | 1.54% |
| Bruce & Co., Inc. | 148,058 | $7,454,000 | 1.44% |
| Bridge City Capital, LLC | 45,843 | $2,308,000 | 1.43% |